InvestorsHub Logo
Followers 2
Posts 22
Boards Moderated 0
Alias Born 12/09/2013

Re: None

Wednesday, 07/23/2014 5:08:15 PM

Wednesday, July 23, 2014 5:08:15 PM

Post# of 48316
Item 5.07 Submission of Matters to a Vote of Security Holders.



On July 18, 2014, OncoSec Medical Incorporated (the “Company”) held its 2014 Annual Meeting of Stockholders (the “Annual Meeting”) at the Company’s principal executive offices located as 9810 Summers Ridge Road, Suite 110, San Diego, California 92121.



The final voting results on the matters presented at the Annual Meeting were as follows:



Proposal 1 — To elect four directors to the Company’s Board of Directors to serve for a term of one year or until successors are duly elected and qualified.



Directors

For

Withheld

Broker Non-Votes


Dr. Avtar Dhillon

41,112,818

2,172,898

127,035,339


Dr. Anthony Maida

41,366,019

1,919,697

127,035,339


Dr. James DeMesa

41,286,019

1,999,697

127,035,339


Punit Dhillon

40,754,531

2,531,185

127,035,339





Proposal 2 — To ratify the appointment of Mayer Hoffman McCann P.C. as the Company’s independent registered public accounting firm for the fiscal year ending July 31, 2014.



For

Against

Abstain

Broker Non-Votes


161,742,142

7,428,061

1,150,852







Proposal 3 — To approve the amendment and restatement of the Company’s 2011 Stock Incentive Plan (the “2011 Plan”) to, among other things, increase the share reserve available under the 2011 Plan by 16,000,000 shares, add an “evergreen” share renewal provision to commence on the first business day of the 2015 calendar year, and increase the annual per person limit on stock options, stock appreciation rights, restricted stock and restricted stock units that are intended to qualify for exclusion from the federal tax deduction limitation under Section 162(m) of the Internal Revenue Code.



For

Against

Abstain

Broker Non-Votes


34,121,439

8,550,033

614,244

127,035,339





1


--------------------------------------------------------------------------------





SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.




ONCOSEC MEDICAL INCORPORATED




Dated: July 23, 2014
By:
/s/ Punit Dhillon



Name: Punit Dhillon



Title: President & Chief Executive Officer




2


--------------------------------------------------------------------------------
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCSQ News